Daniel Kraft is a Stanford and Harvard trained scientist, inventor, entrepreneur, and innovator. He is chair of the XPRIZE Pandemic Alliance working group and is the founder of RegenMed Systems, a company focused on developing stem cell-based regenerative therapies.
With more than 25 years of experience in clinical practice, biomedical research, and health care innovation, he has been Chairman of the School of Medicine at Singularity University since joining in 2008. He is Founder and Chairman of Exponential Medicine, a program that explores rapidly developing converging technologies and their potential in biomedicine and health.
Daniel Kraft's academic research has focused on stem cell biology and regenerative medicine, cancer immunotherapy, and bioengineering. His research has been published in journals such as Nature and Science. He has been involved in digital health, which is why he founded Digital.Health and is on the board of Healthy.io.
With his invention, the MarrowMiner has succeeded in obtaining minimally invasive bone marrow samples. He founded RegenMedSystems, a company that develops regenerative technologies based on the study of stem cells.
He has conducted research in aerospace medicine that has been published by NASA, where he was a finalist in the selection of astronauts.